4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
25.67
16-5月-24 15:59:58
15 分の遅延
株式
+0.09
+0.35%
本日の幅
24.77 - 26.10
ISIN
N/A
ソース
NASDAQ
-
4D Molecular Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
11 2 2022 16:03:00 提供 Nasdaq GlobeNewswire
-
09 2 2022 08:02:00 提供 Nasdaq GlobeNewswire
-
02 2 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
10 1 2022 08:02:00 提供 Nasdaq GlobeNewswire
-
06 1 2022 16:03:04 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
23 11 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
10 11 2021 16:01:01 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Pricing of Public Offering of Common Stock
28 10 2021 21:06:48 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
26 10 2021 17:52:14 提供 Nasdaq GlobeNewswire
-
06 10 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
29 9 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
24 9 2021 07:03:00 提供 Nasdaq GlobeNewswire
-
12 8 2021 16:04:00 提供 Nasdaq GlobeNewswire
-
24 6 2021 07:01:00 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer
07 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
03 6 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
13 5 2021 16:03:00 提供 Nasdaq GlobeNewswire